Determination of genotypes using a fully automated molecular detection system.

  title={Determination of genotypes using a fully automated molecular detection system.},
  author={Gwendolyn Spizz and Zongyuan Chen and Peng Li and Ingrid Mcguire and Paulina Klimkiewicz and Devin A. Zysling and Rubina Yasmin and Whitney Hungerford and Benjamin Thomas and Gregory Wilding and Gregory Mouchka and Lincoln C. Young and Ping Zhou and Richard A. Montagna},
  journal={Archives of pathology & laboratory medicine},
  volume={139 6},
CONTEXT Although the value of pharmacogenomics to improve patient outcomes has become increasingly clear, adoption in medical practice has been slow, which can be attributed to several factors, including complicated and expensive testing procedures and required equipment, lack of training by private practice physicians, and reluctance of both private and commercial payers to reimburse for such testing. OBJECTIVES To evaluate a fully automated molecular detection system for human genotyping… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Explore Further: Topics Discussed in This Paper


Publications referenced by this paper.

EU-PACT Group. A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon

  • TI Verhoef, G Ragia, A de Boer
  • New Eng J Med
  • 2013

Medical Technology as a key driver of rising healthcare expenditure: disengaging the relationship

  • C Sorenson, M Drummond, BB. Khan
  • Clinicoecon Outcomes Res
  • 2013

Plavix (clopidogrel bisulfate) product insert. Bridgewater, New Jersey: Bristol-Myers Squibb. plavix.pdf

  • Bristol-Myers Squibb
  • Updated December
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…